Cargando…

1041. Tenofovir alafenamide associated weight change in persons living with HIV

BACKGROUND: Persons living with human immunodeficiency virus (PLWH) have a higher incidence of developing obesity, diabetes, and cardiovascular disease. TAF, a newer formulation of tenofovir, has favorable effects on renal function and bone mineral density compared to TDF. However, recent evidence s...

Descripción completa

Detalles Bibliográficos
Autores principales: Crowder, Carlysle E, Bouchard, Jeannette, Weissman, Sharon, Derrick, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776994/
http://dx.doi.org/10.1093/ofid/ofaa439.1227